CSL Behring is teaming up with renowned portrait photographer Rankin to launch “Portraits of Progress,” a project that charts 60 years in the fight against hemophilia. CSL, which markets several drugs ...
The Melbourne-based company will build a 330,000-square-foot facility and retain 1,200 existing positions. Construction is ...
The Pennsylvania biotech company CSL Behring says it is on track to file for approval of its hemophilia B gene therapy by the end of June after releasing pivotal data showing statistical superiority ...
The FDA has approved the first hemophilia B gene therapy, a one-time treatment that addresses a root cause of this inherited disorder and potentially eliminates the need for regular infusions that ...
CSL Behring has been honored with this prestigious award recognizing innovation and excellence in pharmaceutical facility projects, as the FOYA program celebrates its 20 th anniversary "As FOYA marks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results